Shyr Y - Search Results

1

15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation.

Gonzalez AL, Roberts RL, Massion PP, Olson SJ, Shyr Y, Shappell SB. Gonzalez AL, et al. Among authors: shyr y. Hum Pathol. 2004 Jul;35(7):840-9. doi: 10.1016/j.humpath.2004.04.001. Hum Pathol. 2004. PMID: 15257547

2

Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas.

Kömhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, Koch MO, Shappell SB, Breyer MD. Kömhoff M, et al. Among authors: shyr y. Am J Pathol. 2000 Jul;157(1):29-35. doi: 10.1016/S0002-9440(10)64513-0. Am J Pathol. 2000. PMID: 10880372 Free PMC article.

3

Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liver.

Washington K, Wright K, Shyr Y, Hunter EB, Olson S, Raiford DS. Washington K, et al. Among authors: shyr y. Hum Pathol. 2000 Jul;31(7):822-8. doi: 10.1053/hupa.2000.8440. Hum Pathol. 2000. PMID: 10923919

4

Hepatic cryoablation-induced acute lung injury: histopathologic findings.

Washington K, Debelak JP, Gobbell C, Sztipanovits DR, Shyr Y, Olson S, Chapman WC. Washington K, et al. Among authors: shyr y. J Surg Res. 2001 Jan;95(1):1-7. doi: 10.1006/jsre.2000.5976. J Surg Res. 2001. PMID: 11120627

5

Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease.

Tham KT, Peek RM Jr, Atherton JC, Cover TL, Perez-Perez GI, Shyr Y, Blaser MJ. Tham KT, et al. Among authors: shyr y. Hum Pathol. 2001 Mar;32(3):264-73. doi: 10.1053/hupa.2001.21136. Hum Pathol. 2001. PMID: 11274634

6

The loss of TGF-beta signaling promotes prostate cancer metastasis.

Tu WH, Thomas TZ, Masumori N, Bhowmick NA, Gorska AE, Shyr Y, Kasper S, Case T, Roberts RL, Shappell SB, Moses HL, Matusik RJ. Tu WH, et al. Among authors: shyr y. Neoplasia. 2003 May-Jun;5(3):267-77. doi: 10.1016/S1476-5586(03)80058-1. Neoplasia. 2003. PMID: 12869309 Free PMC article.

7

Proteomic patterns of tumour subsets in non-small-cell lung cancer.

Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP. Yanagisawa K, et al. Among authors: shyr y. Lancet. 2003 Aug 9;362(9382):433-9. doi: 10.1016/S0140-6736(03)14068-8. Lancet. 2003. PMID: 12927430

8

Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.

Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA, Moses HL. Gorska AE, et al. Among authors: shyr y. Am J Pathol. 2003 Oct;163(4):1539-49. doi: 10.1016/s0002-9440(10)63510-9. Am J Pathol. 2003. PMID: 14507660 Free PMC article.

9

A training-testing approach to the molecular classification of resected non-small cell lung cancer.

Yamagata N, Shyr Y, Yanagisawa K, Edgerton M, Dang TP, Gonzalez A, Nadaf S, Larsen P, Roberts JR, Nesbitt JC, Jensen R, Levy S, Moore JH, Minna JD, Carbone DP. Yamagata N, et al. Among authors: shyr y. Clin Cancer Res. 2003 Oct 15;9(13):4695-704. Clin Cancer Res. 2003. PMID: 14581339

10

Significance of p63 amplification and overexpression in lung cancer development and prognosis.

Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, Westfall MD, Roberts JR, Pietenpol JA, Carbone DP, Gonzalez AL. Massion PP, et al. Among authors: shyr y. Cancer Res. 2003 Nov 1;63(21):7113-21. Cancer Res. 2003. PMID: 14612504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

716 results

Search Page